Sponsor pipeline

Niguarda Hospital clinical trial pipeline

Get alerts when Niguarda Hospital's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-20

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 1 with a notable change, 0 with minor changes only.

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

New trial filings, last 30 days

First postedTrialPhaseStatus
2026-10-19 NCT07879820 PSMA-Guided Surgery and Tissue-Resident T-Cell Profiling in Node-Positive Prostate Cancer Recruiting

Active trials by phase

Phase 2
1
Phase 3
2
Not charted: 27 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Disease areas by active trials, top 10 of 14

Heart Disease (8) · Colorectal Cancer (3) · Heart Failure (3) · Stroke (2) · Breast Cancer (1) · Chronic Lymphocytic Leukemia (CLL) (1) · Coronary Artery Disease (1) · Epilepsy (1) · Gastric Cancer (1) · Kidney Cancer (1)

Get alerts when Niguarda Hospital's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free